Stock comparison
Lantheus Holdings, Inc. is 3.2x more valuable than Intellia Therapeutics, Inc. by market capitalization ($6.90 B vs $2.16 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
LNTH is larger
Lantheus Holdings, Inc. is 3.2x more valuable than Intellia Therapeutics, Inc. by market capitalization ($6.90 B vs $2.16 B).
Market value leader
LNTH
Lantheus Holdings, Inc. is 3.2x more valuable than Intellia Therapeutics, Inc. by market capitalization ($6.90 B vs $2.16 B).
Revenue leader
LNTH
LNTH: $1.54B vs NTLA: $67.67M.
Profit leader
LNTH
LNTH: $233.56M vs NTLA: -$412.69M.
Margin leader
LNTH
LNTH: 15.2% vs NTLA: -609.9% net margin.
| Metric | LNTH | NTLA |
|---|---|---|
| Market cap | $6.90 B | $2.16 B |
| US-listed rank | #1178 | #2076 |
| Revenue (latest FY) | $1.54B | $67.67M |
| Net income (latest FY) | $233.56M | -$412.69M |
| Net margin | 15.2% | -609.9% |
| P/E (trailing FY) | 29.5x | - |
| SEC filings | 1,070 | 679 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Lantheus Holdings, Inc. is 3.2x more valuable than Intellia Therapeutics, Inc. by market capitalization ($6.90 B vs $2.16 B).
In their latest fiscal years, Lantheus Holdings, Inc. reported $1.54B in revenue while Intellia Therapeutics, Inc. reported $67.67M.
Full pages: Lantheus Holdings, Inc. and Intellia Therapeutics, Inc., or browse the full rankings.